Patents by Inventor Pascal André René BENDERITTER

Pascal André René BENDERITTER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Carbazole and carboline compounds for use in the diagnosis, treatment, alleviation or prevention of disorders associated with amyloid or amyloid-like proteins
    Patent number: 10662193
    Abstract: The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: May 26, 2020
    Assignees: AC IMMUNE SA, LIFE MOLECULAR IMAGING SA
    Inventors: Heiko Kroth, Sreenivasachary Nampally, Jér{hacek over (o)}me Molette, Emanuele Gabellieri, Pascal André René Benderitter, Wolfgang Froestl, Hanno Schieferstein, Andre Mueller, Heribert Schmitt-Willich, Mathias Berndt
  • Macrocyclic salt-inducible kinase inhibitors
    Patent number: 9586975
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of SIK kinase, more in particular SIK1, SIK2 and/or SIK3 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of SIK-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 7, 2017
    Assignee: ONCODESIGN S.A.
    Inventors: Petra Marcella Francoise Blom, Jan Marie Cyriel Jozef Hoflack, Pascal Andre Rene Benderitter
  • Carbazole and Carboline Compounds for Use in the Diagnosis, Treatment, Alleviation or Prevention of Disorders Associated with Amyloid or Amyloid-Like Proteins
    Publication number: 20170002005
    Abstract: The present invention relates to novel compounds that can be employed in the diagnosis, treatment, alleviation or prevention of a group of disorders and abnormalities associated with amyloid proteins and amyloid-like proteins, such as Alzheimer's disease. Precursors for the preparation of the compounds according to the present invention are also provided.
    Type: Application
    Filed: January 21, 2015
    Publication date: January 5, 2017
    Inventors: Heiko KROTH, Sreenivasachary NAMPALLY, Jérôme MOLETTE, Emanuele GABELLIERI, Pascal André René BENDERITTER, Wolfgang FROESTL, Hanno SCHIEFERSTEIN, Andre MUELLER, Heribert SCHMITT-WILLICH, Mathias BERNDT
  • MACROCYCLIC SALT-INDUCIBLE KINASE INHIBITORS
    Publication number: 20160024113
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of SIK kinase, more in particular SIK1, SIK2 and/or SIK3 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of SIK-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Applicant: ONCODESIGN S.A.
    Inventors: Petra Marcella, Francoise BLOM, Jan Marie, Cyriel, Jozef HOFLACK, Pascal Andre, Rene BENDERITTER
  • MACROCYCLIC RIP2 KINASE INHIBITORS
    Publication number: 20160024114
    Abstract: The present invention relates to macrocyclic compounds and compositions containing said compounds acting as kinase inhibitors, in particular as inhibitors of RIP2 and/or mutants thereof, for use in the diagnosis, prevention and/or treatment of RIP2-kinase associated diseases. Moreover, the present invention provides methods of using said compounds, for instance as a medicine or diagnostic agent.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Applicant: ONCODESIGN S.A.
    Inventors: Petra Marcella, Francoise Blom, Jan Marie Cyriel Jozef Hoflack, Pascal Andre, Rene Benderitter